Recent News

• 03.10.2025 - Fennec Pharmaceuticals Q4 2024 Conference Call
• 03.10.2025 - Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
• 03.10.2025 - Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
• 03.06.2025 - Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025
• 03.06.2025 - Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025
• 02.07.2025 - FENNEC PHARMACEUTICALS ANNOUNCES COMMERCIAL LAUNCH OF PEDMARQSI® IN GERMANY
• 02.07.2025 - Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany
• 02.07.2025 - Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany

Recent Filings

• 03.10.2025 - 8-K Current report
• 03.10.2025 - EX-99.1 EX-99.1
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 144 Report of proposed sale of securities
• 02.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - 144 Report of proposed sale of securities
• 02.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors